Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 947896, 2 pages

Anti-Inflammatory Therapy in Diabetic Retinopathy

Department of Clinical and Experimental Endocrinology, Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, Powstania Styczniowego 9b, 81-519 Gdynia, Poland

Received 14 January 2014; Accepted 14 January 2014; Published 23 February 2014

Copyright © 2014 Katarzyna Zorena. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Chakrabarti, C. A. Harper, and J. E. Keeffe, “Diabetic retinopathy management guidelines,” Expert Review of Ophthalmology, vol. 7, no. 5, pp. 417–439, 2012. View at Publisher · View at Google Scholar
  2. K. Su and J. de Vellis, “Microglia in health and disease,” Journal of Neuroscience Research, vol. 81, no. 3, pp. 302–313, 2005. View at Publisher · View at Google Scholar
  3. P. Mitchell, F. Bandello, U. Schmidt-Erfurth et al., “The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema,” Ophthalmology, vol. 118, no. 4, pp. 615–625, 2011. View at Publisher · View at Google Scholar